Improving liver fibrosis prediction: Integrating vitamin D, leptin, APRI, and FIB-4 :- Medznat
EN | RU
EN | RU

Help Support

By clicking the "Submit" button, you accept the terms of the User Agreement, including those related to the processing of your personal data. More about data processing in the Policy.
Back

Non-invasive biomarkers in liver fibrosis and transplant outcomes

Liver transplantation Liver transplantation
Liver transplantation Liver transplantation

Liver fibrosis, a progressive pathological condition, is marked by abnormally high accumulation of extracellular matrix components, ultimately leading to cirrhosis and hepatocellular carcinoma if left unchecked.

See All

Key take away

Serum leptin, vitamin D, and APRI serve as dynamic non-invasive biomarkers reflecting liver fibrosis severity and recovery following liver transplantation.

Background

Liver fibrosis, a progressive pathological condition, is marked by abnormally high accumulation of extracellular matrix components, ultimately leading to cirrhosis and hepatocellular carcinoma if left unchecked. Although liver biopsy remains the gold standard for fibrosis assessment, its invasive nature has driven increasing reliance on non-invasive biomarkers such as aspartate aminotransferase to platelet count ratio (APRI), fibrosis-4 (FIB-4), leptin, and vitamin D for evaluating disease severity and progression.

Researchers aimed to evaluate the clinical significance of leptin, vitamin D, APRI, and FIB-4 in patients with liver fibrosis before and after liver transplantation and to assess their potential role in disease progression and post-transplant recovery.

Method

This interventional study included 50 people with liver fibrosis who underwent transplantation of liver. Serum leptin and vitamin D levels were measured pre-transplant and at three and six months post-transplant using enzyme-linked immunosorbent assay (ELISA). APRI and FIB-4 scores were examined to check liver fibrosis severity. Qualitative proteomic analysis was performed to identify serum proteins associated with liver fibrosis, including extracellular matrix components. For statistical assessment, one-way ANOVA was employed to compare biomarker levels across time points.

Result

Patients with liver fibrosis demonstrated markedly elevated leptin concentrations and APRI indices compared to controls, with both markers showing a consistent and significant decline following liver transplantation at three and six months. In contrast, vitamin D levels were significantly suppressed at baseline but exhibited a marked postoperative increase.

ROC curve analysis confirmed excellent diagnostic accuracy, with area under the curve values reaching 1.0 for vitamin D and 0.997 for leptin. Integrated proteomic and bioinformatics analyses revealed that the identified protein set was significantly enriched in extracellular matrix organization, immune modulation, and fibrosis-related pathways. The Search Tool for the Retrieval of Interacting Genes (STRING) network mapping further demonstrated a tightly interconnected protein interaction network involving leptin and vitamin D, highlighting their potential regulatory role in extracellular matrix remodeling and liver fibrosis pathophysiology.

Conclusion

Serum vitamin D and leptin proved to be highly accurate, non-invasive biomarkers for liver fibrosis, with strong diagnostic and prognostic potential. When combined with APRI and FIB-4 scores, these markers offer a powerful approach for early detection, disease monitoring, and post-transplant evaluation in chronic liver disease and cirrhosis.

Source:

BMC Gastroenterology

Article:

Leptin, vitamin D, and APRI values during the six months post-liver transplantation

Authors:

Yasmine A. Algobashy et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru
Try: